OXYSURE (OXYS) DOUBLES ORGANIC SALES PLAN FOR 2015
Frisco, Texas, November 24, 2014 – OxySure Systems, Inc. (OTCQB: OXYS) (“OxySure,” or the “Company”), a global leader and medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its “oxygen from powder” technology today announced that the Company has doubled its organic growth plan for 2015.
On September 18, 2014 the Company announced that it has appointed Clark E. Hood, a 16 year veteran in the AED and resuscitation industry as Vice President of Worldwide Resuscitation Sales, effective October 1, 2014. A copy of the announcement can be found here:
Hood was chosen due to his proven track record to deliver revenue growth through strategic account development. This, combined with recent developments has prompted the Company to aggressively expand Hood's initial goal of 15 people by year-end 2015 to about 30 new sales leaders.
Said Julian T. Ross, Chairman & CEO of OxySure: “The Board and I are laser focused on making sure every decision we make delivers the best value for shareholders. By doubling the organic growth plan we get to our previously announced goal of achieving a $10 million revenue run rate in 2015, without, or prior to any external growth options that might be available to us, now or in the immediately foreseeable future. We are and remain committed to our medical device platform strategy, but at each decision point we need to ask ourselves how much dilution we are willing to suffer in return for the additional growth we gain.”
“This is the right move for the Company to insure its stated growth goals for 2015 and beyond,” said Board Director Vicki Jones. “With this revised sales baseline as a backdrop, we are better positioned to evaluate any inorganic growth opportunities, now and in the immediately foreseeable future, as we evaluate factors such as dilution, acquisition cost, and other expectations regarding fundamentals for each opportunity.”
Said Clark Hood, VP of Resuscitation Sales Worldwide: “I am pleased that the Board has entrusted me with an acceleration of the organic sales growth plan. I have built large sales teams in the AED industry before, selling hundreds of millions of dollars in AEDs and emergency medical products. I look forward to the challenge and I am confident our updated strategy will yield a significant return for our Company and shareholders.”
About OxySure Systems, Inc.
OxySure Systems, Inc. (OXYS) is a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions. The company pioneered a safe and easy to use solution to produce medically pure (USP) oxygen from inert powders. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems. OxySure's products improve access to emergency oxygen that affects the survival, recovery and safety of individuals in several areas of need: (1) Public and private places and settings where medical emergencies can occur; (2) Individuals at risk for cardiac, respiratory or general medical distress needing immediate help prior to emergency medical care arrival; and (3) Those requiring immediate protection and escape from exposure situations or oxygen-deficient situations in industrial, mining, military, or other "Immediately Dangerous to Life or Health" (IDLH) environments. www.OxySure.com
Statements in this earnings release that are not historical facts are considered to be forward-looking statements. Such statements include, but are not limited to, statements regarding management beliefs and expectations, based upon information available at the time the statements are made, regarding future plans, objectives and performance. All forward-looking statements are subject to risks and uncertainties, many of which are beyond management’s control and actual results and performance may differ significantly from those contained in forward-looking statements. OxySure Systems, Inc. intends any forward-looking statement to be covered by the Litigation Reform Act of 1995 and is including this statement for purposes of said safe harbor provisions. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this news release. OxySure Systems, Inc. undertakes no obligation to update any forward-looking statements to reflect events or circumstances that occur after the date as of which such statements are made. A discussion of certain risks and uncertainties that could cause actual results to differ materially from those contained in forward-looking statements is included in OxySure Systems, Inc.’s Annual Report on Form 10-K for the year ended December 31, 2013.
Stonegate Securities, Inc.
214-987-4121 / 972-294-6461
Renmark Financial Communications, Inc.
Bettina Filippone: email@example.com
John Boidman: firstname.lastname@example.org
Tel.: (416) 644-2020 or (514) 939-3989